Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Canji Inc
Profile last edited on: 5/31/17      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1990
First Award
1994
Latest Award
1995
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

3525 John Hopkins Court
San Diego, CA 92121
   (619) 597-0177
   N/A
   www.sgp.com
Location: Single
Congr. District: 52
County: San Diego

Public Profile

Originally formed to commercialize suppressor oncogene technology developed by Dr. Wen-Hwa Lee of the University of California at San Diego. Canji, Inc. is a biotechnology company which develops innovative therapeutics based on tumor suppressor genes, cell-cycle regulators and growth modulators. As of February 1, 1996, became a wholly owned subsidiary of Schering-Plough Corporation

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$159,063
Phase II Dollars
$0
Total Awarded
$159,063

Synopsis: Awardee Business Condition

Employee Range
75-99
Revenue Range
7.5M-10M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
75-99

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
1995 1 NIH $85,710
Project Title: Cloning Human Disease Genes by Selection-Subtraction
1994 1 NIH $73,353
Project Title: Quantitation of allelic imbalance in solid tumors

Key People / Management

  Donald R Conklin -- President

  Robert E Bookstein

Company News

There are no news available.